The U.S. Food and Drug Administration has reportedly targeted a manufacturer of poppers, an inhalant drug that has gained ...
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Neil Walker was given contaminated blood products when he was a baby and contracted HIV at 12-years-old. | ITV News Central ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
1d
Clinical Trials Arena on MSNViiV to trial twice-yearly HIV antibody dosing after Phase IIb successThe company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
It was later discovered that one of the donors was HIV positive, leading to her infection..HIV, AIDS, Cancer patient, RCC, Kerala High Court ...
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
The Infected Blood Inquiry said it will publish a further report looking at the adequacy of the Government’s approach to compensation.
The victims and families of the infected blood scandal have been left "distressed and powerless" because of the government's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results